Quantification of tear proteins and sPLA2-IIa alteration in patients with allergic conjunctivitis

Molecular Vision

Volumn 16, Issue , 2010, Pages 2084-2091

  Li, Kaijun ^a   Liu, Xialin ^a   Chen, Ziyan ^a   Huang, Qiang ^a   Wu, Kaili ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN KAPPA CHAIN; LACTOFERRIN; LEUKOCYTE ELASTASE INHIBITOR; LIPOCALIN 1; LIPOCORTIN 1; LYSOZYME; PHOSPHOLIPASE A2 GROUP II; PREALBUMIN; SERUM ALBUMIN PRECURSOR; SOYBEAN TRYPSIN INHIBITOR; TEAR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DENSITOMETRY; DRY EYE; EPIPHORA; EYE BURNING; EYE EXAMINATION; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LACRIMAL FLUID; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OCULAR PRURITUS; PERENNIAL ALLERGIC CONJUNCTIVITIS; PHOTOPHOBIA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN EXPRESSION; QUESTIONNAIRE; SCHIRMER TEST; SEASONAL ALLERGIC CONJUNCTIVITIS; TEAR FILM; WESTERN BLOTTING;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CONJUNCTIVITIS, ALLERGIC; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EYE; EYE PROTEINS; FEMALE; GROUP II PHOSPHOLIPASES A2; HUMANS; MALE; QUESTIONNAIRES; REFERENCE STANDARDS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TEARS; YOUNG ADULT;

EID: 78149476508     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Riedi CA, Rosario NA. Prevalence of allergic conjunctivitis: a missed opportunity? Allergy 2010; 65:131-2.
2. Toda I, Shimazaki J, Tsubota K. Dry eye with only decreased tear break-up time is sometimes associated with allergic conjunctivitis. Ophthalmology 1995; 102:302-9.
3. Lobefalo L, D'Antonio E, Colangelo L, Della Loggia G, Di Gioacchino M, Angelucci D, Di Iorio A, Gallenga PE. Dry eye in allergic conjunctivitis: role of inflammatory infiltrate. Int J Immunopathol Pharmacol 1999; 12:133-7.
4. Berdy GJ, Hedqvist B. Ocular allergic disorders and dry eye disease: associations, diagnostic dilemmas, and management. Acta Ophthalmol Scand Suppl 2000; 230:32-7.
5. Dogru M, Katakami C, Nakagawa N, Tetsumoto K, Yamamoto M. Impression cytology in atopic dermatitis. Ophthalmology 1998; 105:1478-84.
6. Di Gioacchino M, Cavallucci E, Di Sciascio MB, Di Stefano F, Verna N, Lobefalo L, Crudeli C, Volpe AR, Angelucci D, Cuccurullo F, Conti P. Increase in CD45RO+ cells and activated eosinophils in chronic allergic conjunctivitis. Immunobiology 2000; 201:541-51.
7. Versura P, Maltarello MC, Caramazza R, Laschi R. Mucus alteration and eye dryness. A possible relationship. Acta Ophthalmol (Copenh) 1989; 67:455-64.
8. Suzuki S, Goto E, Dogru M, Asano-Kato N, Matsumoto Y, Hara Y, Fujishima H, Tsubota K. Tear film lipid layer alterations in allergic conjunctivitis. Cornea 2006; 25:277-80.
9. Coyle PK, Sibony PA, Johnson C. Electrophoresis combined with immunologic identification of human tear proteins. Invest Ophthalmol Vis Sci 1989; 30:1872-8.
10. Gachon AM, Verrelle P, Betail G, Dastugue B. Immunological and electrophoretic studies of human tear proteins. Exp Eye Res 1979; 29:539-53.
11. Kuizenga A, van Haeringen fnameNJ/fname, Kijlstra A. SDS-Minigel electrophoresis of human tears. Effect of sample treatment on protein patterns. Invest Ophthalmol Vis Sci 1991; 32:381-6.
12. Green-Church KB, Nichols KK, Kleinholz NM, Zhang L, Nichols JJ. Investigation of the human tear film proteome using multiple proteomic approaches. Mol Vis 2008; 14:456-70.
13. Nomura K, Takamura E. Tear IgE concentrations in allergic conjunctivitis. Eye (Lond) 1998; 12:296-8.
14. Sainte Laudy J, Couturier P, Basset-Stheme D. Importance of the lacrymal levels (total IgE, specific IgE and albumin) for the study of allergic conjunctivitis. Allerg Immunol (Paris) 1994; 26:95-6.
15. Kari O, Salo OP, Bjorksten F, Backman A. Allergic conjunctivitis, total and specific IgE in the tear fluid. Acta Ophthalmol (Copenh) 1985; 63:97-9.
16. Li K, Chen Z, Duan F, Liang J, Wu K. Quantification of tear proteins by SDS-PAGE with an internal standard protein. A new method with special reference to small volume tears. Graefes Arch Clin Exp Ophthalmol 2010; 248:853-62.
17. Saari KM, Aho V, Paavilainen V, Nevalainen TJ. Group II PLA(2) content of tears in normal subjects. Invest Ophthalmol Vis Sci 2001; 42:318-20.
18. Beers SA, Buckland AG, Koduri RS, Cho W, Gelb MH, Wilton DC. The antibacterial properties of secreted phospholipases A2: a major physiological role for the group IIA enzyme that depends on the very high pI of the enzyme to allow penetration of the bacterial cell wall. J Biol Chem 2002; 277:1788-93.
19. Girgis DO, Dajcs JJ, O'Callaghan RJ. Phospholipase A2 activity in normal and Staphylococcus aureus-infected rabbit eyes. Invest Ophthalmol Vis Sci 2003; 44:197-202.
20. Nevalainen TJ, Graham GG, Scott KF. Antibacterial actions of secreted phospholipases A2. Review. Biochim Biophys Acta 2008; 1781:1-9.
21. Chen D, Wei Y, Li X, Epstein S, Wolosin JM, Asbell P. sPLA2- IIa is an inflammatory mediator when the ocular surface is compromised. Exp Eye Res 2009; 88:880-8.
22. Mantelli F, Lambiase A, Bonini S. A simple and rapid diagnostic algorithm for the detection of ocular allergic diseases. Curr Opin Allergy Clin Immunol 2009; 9:471-6.
23. Buckley RJ. Allergic eye disease-a clinical challenge. Clin Exp Allergy 1998; 28:39-43.
24. Leonardi A, Curnow SJ, Zhan H, Calder VL. Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures. Clin Exp Allergy 2006; 36:777-84.
25. Yu M, Sun J, Peng W, Chen Z, Lin X, Liu X, Li M, Wu K. Protein expression in human trabecular meshwork: downregulation of RhoGDI by dexamethasone in vitro. Mol Vis 2010; 16:213-23.
26. Keane-Myers A. The pathogenesis of allergic conjunctivitis. Curr Allergy Asthma Rep 2001; 1:550-7.
27. McGill JI, Holgate ST, Church MK, Anderson DF, Bacon A. Allergic eye disease mechanisms. Br J Ophthalmol 1998; 82:1203-14.
28. Jakab L. Pathogenesis of different forms of allergic conjunctivitis. Orv Hetil 1999; 140:1438-9.
29. Miyazaki D, Tominaga T, Yakura K, Kuo CH, Komatsu N, Inoue Y, Ono SJ. Conjunctival mast cell as a mediator of eosinophilic response in ocular allergy. Mol Vis 2008; 14:1525-32.
30. Acar N, Toker E, Kazokoglu H. Tear and serum eosinophil cationic protein levels in seasonal allergic conjunctivitis. Eur J Ophthalmol 2003; 13:671-5.
31. Montan PG, van Hage-Hamsten M. Eosinophil cationic protein in tears in allergic conjunctivitis. Br J Ophthalmol 1996; 80:556-60.
32. Li N, Wang N, Zheng J. X. Michael Liu, O. William Lever, Paul M. Erickson, Liang Li. Characterization of Human Tear Proteome Using Multiple Proteomic Analysis Techniques. J Proteome Res 2005; 4:2052-61.
33. Rapacz P, Tedesco J, Donshik PC, Ballow M. Tear lysozyme and lactoferrin levels in giant papillary conjunctivitis and vernal conjunctivitis. CLAO J 1998; 14:207-9.
34. Ballow M, Donshik PC, Rapacz P, Samartino L. Tear lactoferrin levels in patients with external inflammatory ocular disease. Invest Ophthalmol Vis Sci 1987; 28:543-5.
35. Dennis EA. Diversity of group types, regulation, and function of phospholipase A2. J Biol Chem 1994; 269:13057-60.
36. Fijneman RJ, Cormier RT. The roles of sPLA2-IIA (Pla2g2a) in cancer of the small and large intestine. Front Biosci 2008; 13:4144-74.
37. Mayer RJ, Marshall LA. New insights on mammalian phospholipase A2(s); comparison of arachidonoyl-selective and -nonselective enzymes. FASEB J 1993; 7:339-48.
38. Adibhatla RM, Hatcher JF. Secretory phospholipase A2 IIA is up-regulated by TNF-alpha and IL-1alpha/beta after transient focal cerebral ischemia in rat. Brain Res 2007; 1134:199-205.
39. Lambeau G, Gelb MH. Biochemistry and physiology of mammalian secreted phospholipases A2. Annu Rev Biochem 2008; 77:495-520.
40. Menschikowski M, Hagelgans A, Siegert G. Secretory phospholipase A2 of group IIA: is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases? Prostaglandins Other Lipid Mediat 2006; 79:1-33.